ID   AG10B_RAT               Reviewed;         474 AA.
AC   O88788;
DT   08-NOV-2005, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   02-OCT-2024, entry version 125.
DE   RecName: Full=Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-glucosyltransferase {ECO:0000250|UniProtKB:Q5I7T1};
DE            EC=2.4.1.256 {ECO:0000250|UniProtKB:Q5I7T1};
DE   AltName: Full=Alpha-1,2-glucosyltransferase ALG10-A;
DE   AltName: Full=Alpha-2-glucosyltransferase ALG10-B;
DE   AltName: Full=Asparagine-linked glycosylation protein 10 homolog B {ECO:0000312|RGD:708500};
DE   AltName: Full=Potassium channel regulator 1 {ECO:0000303|PubMed:9722534};
GN   Name=Alg10b {ECO:0000312|RGD:708500};
GN   Synonyms=Kcr1 {ECO:0000303|PubMed:9722534};
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], INTERACTION WITH KCNH1, SUBCELLULAR LOCATION,
RP   AND TISSUE SPECIFICITY.
RC   STRAIN=Wistar; TISSUE=Cerebellum;
RX   PubMed=9722534; DOI=10.1074/jbc.273.36.23080;
RA   Hoshi N., Takahashi H., Shahidullah M., Yokoyama S., Higashida H.;
RT   "KCR1, a membrane protein that facilitates functional expression of non-
RT   inactivating K+ currents associates with rat EAG voltage-dependent K+
RT   channels.";
RL   J. Biol. Chem. 273:23080-23085(1998).
RN   [2]
RP   INTERACTION WITH KCNH2, AND SUBCELLULAR LOCATION.
RX   PubMed=14525949; DOI=10.1096/fj.02-1057fje;
RA   Kupershmidt S., Yang I.C.-H., Hayashi K., Wei J., Chanthaphaychith S.,
RA   Petersen C.I., Johns D.C., George A.L. Jr., Roden D.M., Balser J.R.;
RT   "The IKr drug response is modulated by KCR1 in transfected cardiac and
RT   noncardiac cell lines.";
RL   FASEB J. 17:2263-2265(2003).
CC   -!- FUNCTION: Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-
CC       glucosyltransferase that operates in the biosynthetic pathway of
CC       dolichol-linked oligosaccharides, the glycan precursors employed in
CC       protein asparagine (N)-glycosylation. The assembly of dolichol-linked
CC       oligosaccharides begins on the cytosolic side of the endoplasmic
CC       reticulum membrane and finishes in its lumen. The sequential addition
CC       of sugars to dolichol pyrophosphate produces dolichol-linked
CC       oligosaccharides containing fourteen sugars, including two GlcNAcs,
CC       nine mannoses and three glucoses. Once assembled, the oligosaccharide
CC       is transferred from the lipid to nascent proteins by
CC       oligosaccharyltransferases. In the lumen of the endoplasmic reticulum,
CC       adds the third and last glucose residue from dolichyl phosphate glucose
CC       (Dol-P-Glc) onto the lipid-linked oligosaccharide intermediate
CC       Glc(2)Man(9)GlcNAc(2)-PP-Dol to produce Glc(3)Man(9)GlcNAc(2)-PP-Dol.
CC       {ECO:0000250|UniProtKB:Q5I7T1}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a di-trans,poly-cis-dolichyl beta-D-glucosyl phosphate + an
CC         alpha-D-Glc-(1->3)-alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-
CC         (1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-
CC         [alpha-D-Man-(1->2)-alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-
CC         Man-(1->4)-beta-D-GlcNAc-(1->4)-alpha-D-GlcNAc-diphospho-di-
CC         trans,poly-cis-dolichol = a alpha-D-Glc-(1->2)-alpha-D-Glc-(1->3)-
CC         alpha-D-Glc-(1->3)-alpha-D-Man-(1->2)-alpha-D-Man-(1->2)-alpha-D-Man-
CC         (1->3)-[alpha-D-Man-(1->2)-alpha-D-Man-(1->3)-[alpha-D-Man-(1->2)-
CC         alpha-D-Man-(1->6)]-alpha-D-Man-(1->6)]-beta-D-Man-(1->4)-beta-D-
CC         GlcNAc-(1->4)-alpha-D-GlcNAc-diphospho-di-trans,poly-cis-dolichol + a
CC         di-trans,poly-cis-dolichyl phosphate + H(+); Xref=Rhea:RHEA:29543,
CC         Rhea:RHEA-COMP:19498, Rhea:RHEA-COMP:19502, Rhea:RHEA-COMP:19512,
CC         Rhea:RHEA-COMP:19522, ChEBI:CHEBI:15378, ChEBI:CHEBI:57525,
CC         ChEBI:CHEBI:57683, ChEBI:CHEBI:132522, ChEBI:CHEBI:132523;
CC         EC=2.4.1.256; Evidence={ECO:0000250|UniProtKB:Q5I7T1};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:29544;
CC         Evidence={ECO:0000250|UniProtKB:Q5I7T1};
CC   -!- PATHWAY: Protein modification; protein glycosylation.
CC       {ECO:0000250|UniProtKB:Q5I7T1}.
CC   -!- SUBUNIT: Interacts with KCNH1; may regulate KCNH1, possibly by
CC       regulating its N-glycosylation (Probable). Interacts with KCNH2; may
CC       reduce KCNH2 sensitivity to classic proarrhythmic drug blockade,
CC       possibly by regulating its N-glycosylation (PubMed:14525949).
CC       {ECO:0000269|PubMed:14525949, ECO:0000305|PubMed:9722534}.
CC   -!- SUBCELLULAR LOCATION: Endoplasmic reticulum membrane
CC       {ECO:0000269|PubMed:9722534}; Multi-pass membrane protein
CC       {ECO:0000255}. Note=Also detected at the plasma membrane.
CC       {ECO:0000269|PubMed:14525949}.
CC   -!- TISSUE SPECIFICITY: Highly expressed in brain, skeletal muscle, uterus,
CC       small intestine and liver. Moderately expressed in lung and kidney.
CC       Weakly expressed in heart and stomach. {ECO:0000269|PubMed:9722534}.
CC   -!- SIMILARITY: Belongs to the ALG10 glucosyltransferase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; U78090; AAC34249.1; -; mRNA.
DR   RefSeq; NP_620801.1; NM_139101.2.
DR   AlphaFoldDB; O88788; -.
DR   STRING; 10116.ENSRNOP00000019672; -.
DR   CAZy; GT59; Glycosyltransferase Family 59.
DR   PhosphoSitePlus; O88788; -.
DR   PaxDb; 10116-ENSRNOP00000019672; -.
DR   Ensembl; ENSRNOT00000019672.6; ENSRNOP00000019672.2; ENSRNOG00000014511.6.
DR   Ensembl; ENSRNOT00055020746; ENSRNOP00055016732; ENSRNOG00055012199.
DR   Ensembl; ENSRNOT00060011015; ENSRNOP00060008215; ENSRNOG00060006725.
DR   GeneID; 245960; -.
DR   KEGG; rno:245960; -.
DR   AGR; RGD:708500; -.
DR   CTD; 84920; -.
DR   RGD; 708500; Alg10b.
DR   eggNOG; KOG2642; Eukaryota.
DR   GeneTree; ENSGT00390000012906; -.
DR   HOGENOM; CLU_017053_1_0_1; -.
DR   InParanoid; O88788; -.
DR   OMA; YRTPQRI; -.
DR   OrthoDB; 50992at2759; -.
DR   PhylomeDB; O88788; -.
DR   TreeFam; TF300150; -.
DR   UniPathway; UPA00378; -.
DR   PRO; PR:O88788; -.
DR   Proteomes; UP000002494; Chromosome 7.
DR   Bgee; ENSRNOG00000014511; Expressed in duodenum and 18 other cell types or tissues.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005789; C:endoplasmic reticulum membrane; ISS:UniProtKB.
DR   GO; GO:0106073; F:dolichyl pyrophosphate Glc2Man9GlcNAc2 alpha-1,2-glucosyltransferase activity; ISS:UniProtKB.
DR   GO; GO:0060117; P:auditory receptor cell development; IEA:Ensembl.
DR   GO; GO:0006488; P:dolichol-linked oligosaccharide biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0071805; P:potassium ion transmembrane transport; IDA:RGD.
DR   GO; GO:0006487; P:protein N-linked glycosylation; ISS:UniProtKB.
DR   GO; GO:0007605; P:sensory perception of sound; IEA:Ensembl.
DR   InterPro; IPR016900; Alg10.
DR   PANTHER; PTHR12989; ALPHA-1,2-GLUCOSYLTRANSFERASE ALG10; 1.
DR   PANTHER; PTHR12989:SF10; DOL-P-GLC:GLC(2)MAN(9)GLCNAC(2)-PP-DOL ALPHA-1,2-GLUCOSYLTRANSFERASE-RELATED; 1.
DR   Pfam; PF04922; DIE2_ALG10; 1.
DR   PIRSF; PIRSF028810; Alpha1_2_glucosyltferase_Alg10; 1.
PE   1: Evidence at protein level;
KW   Endoplasmic reticulum; Glycosyltransferase; Membrane; Reference proteome;
KW   Transferase; Transmembrane; Transmembrane helix.
FT   CHAIN           1..474
FT                   /note="Dol-P-Glc:Glc(2)Man(9)GlcNAc(2)-PP-Dol alpha-1,2-
FT                   glucosyltransferase"
FT                   /id="PRO_0000215449"
FT   TOPO_DOM        1..6
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        7..27
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        28..64
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        65..85
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        86..97
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        98..118
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        119..126
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        127..147
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        148..150
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        151..171
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        172..175
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        176..196
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        197..256
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        257..277
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        278..283
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        284..304
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        305..317
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        318..338
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        339..365
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        366..386
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        387..392
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        393..413
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        414..436
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        437..457
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        458..473
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
SQ   SEQUENCE   474 AA;  55574 MW;  0901C1DEA9C7B9E9 CRC64;
     MAQLEGYYFS AALSCTFLVS CLLFSAFSRA LREPYMDEIF HLPQAQRYCE GRFSLSQWDP
     MITTLPGLYL VSVGVVKPAS WILGWSEHVV CSIGMLRFVN LLFSVGNFYL LYLLFRKIQP
     RNKASSSIQR ILSTLTLAVF PTLYFFNFLY YTEAGSVFFT LFAYLMCLYG NHRTSALLGF
     CGFMFRQTNI IWAAFCAGHI IAQKCSEAWK TELQKKKEER LPPAKGPLSE LRRVLQFLLM
     YSMSLKNLSM LFLLTWPYML LLLAFFVFVV VNGGIVVGDR SSHEACLHFP QLFYFFSFTA
     FFSFPHLLSP TKVKTFLSLV WKRRVQFSVI TLVSVFLVWK FTYVHKYLLA DNRHYTFYVW
     KRVFQRHEIV KYLLVPAYMF AGWAVADSLK SKSIFWNLMF FVCLVASTVP QKLLEFRYFI
     LPYIIYRLNM PLPPISRLVC ELGCYAVVNF LTFYIFLNKT FQWSDSHDIQ RFMW
//
